{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "5224",
          "submission_status": "AP",
          "submission_status_date": "20151203",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "39773",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103976s5224lbl.pdf",
              "date": "20151208",
              "type": "Label"
            },
            {
              "id": "9530",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/103976Orig1s5224ltr.pdf",
              "date": "20151208",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5087",
          "submission_status": "AP",
          "submission_status_date": "20060407",
          "submission_class_code": "S",
          "submission_class_code_description": "Supplement",
          "application_docs": [
            {
              "id": "18720",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/103976s5097lbl.pdf",
              "date": "20060414",
              "type": "Label"
            },
            {
              "id": "31755",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/103976s5097ltr.pdf",
              "date": "20060414",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5166",
          "submission_status": "AP",
          "submission_status_date": "20100104",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "31756",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/103976s5166ltr.pdf",
              "date": "20100205",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5180",
          "submission_status": "AP",
          "submission_status_date": "20101221",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "31757",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/103976s5180ltr.pdf",
              "date": "20110110",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5239",
          "submission_status": "AP",
          "submission_status_date": "20210722",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "70560",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103976s5239lbl.pdf",
              "date": "20220318",
              "type": "Label"
            },
            {
              "id": "70561",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103976s5239lbl.pdf",
              "date": "20220318",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5245",
          "submission_status": "AP",
          "submission_status_date": "20240216",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "77511",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103976s5245lbl.pdf",
              "date": "20240216",
              "type": "Label"
            },
            {
              "id": "77512",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103976s5245lbl.pdf#page=45",
              "date": "20240216",
              "type": "Medication Guide"
            },
            {
              "id": "77574",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/103976Orig1s5245ltr.pdf",
              "date": "20240220",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5243",
          "submission_status": "AP",
          "submission_status_date": "20230317",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73806",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/103976Orig1s5243ltr.pdf",
              "date": "20230320",
              "type": "Letter"
            },
            {
              "id": "74164",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976Orig1s5243lbl.pdf",
              "date": "20230503",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5154",
          "submission_status": "AP",
          "submission_status_date": "20090724",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5235",
          "submission_status": "AP",
          "submission_status_date": "20201130",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "65444",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103976s5235lbl.pdf",
              "date": "20201201",
              "type": "Label"
            },
            {
              "id": "65468",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/103976Orig1s5235ltr.pdf",
              "date": "20201202",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5225",
          "submission_status": "AP",
          "submission_status_date": "20160706",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "51622",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "51623",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab clinpharm-prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "51624",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab statistical-prea.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "9531",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/103976Orig1s5225ltr.pdf",
              "date": "20160707",
              "type": "Letter"
            },
            {
              "id": "18723",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/103976s5225lbl.pdf",
              "date": "20160708",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5231",
          "submission_status": "AP",
          "submission_status_date": "20180928",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "55768",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/103976Orig1s5231ltr.pdf",
              "date": "20181001",
              "type": "Letter"
            },
            {
              "id": "55798",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103976s5231lbl.pdf",
              "date": "20181003",
              "type": "Label"
            },
            {
              "id": "65848",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/103976Orig1s5231.pdf",
              "date": "20210107",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5191",
          "submission_status": "AP",
          "submission_status_date": "20111222",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "31758",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/103976s5191ltr.pdf",
              "date": "20120105",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5211",
          "submission_status": "AP",
          "submission_status_date": "20140321",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "65849",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/103976Orig1s5211.pdf",
              "date": "20210107",
              "type": "Review"
            },
            {
              "id": "18722",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103976s5211lbl.pdf",
              "date": "20140325",
              "type": "Label"
            },
            {
              "id": "31759",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/103976Orig1s5211ltr.pdf",
              "date": "20140325",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20030620",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "44424",
              "url": "http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm103291.htm",
              "date": "20040330",
              "type": "Other Important Information from FDA"
            },
            {
              "id": "51619",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "51620",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab clinpharm prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "51621",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab statistical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "63186",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/Omalizumab---Xolair-Clinical-Pharmacology-Review--New-Genentech--Inc.-and-Novartis-Pharmaceuticals-Corp..pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "63187",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/Omalizumab---Xolair--Statistical-Review-Memo-New-Genentech--Inc.-and-Novartis-Pharmaceuticals-Corp.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "63188",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/339_103976S5231 omalizumab multidisciplinary prea.pdf",
              "date": "19000101",
              "type": "Pediatric Other"
            },
            {
              "id": "64995",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976-Omalizumab-multidisciplinary-prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "68903",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "68904",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab clinpharm prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "68905",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976 omalizumab statistical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "68906",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976s5149_Omalizumab_Clinical_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "68907",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976s5149_Omalizumab_Clinical2_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "68908",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976s5149_Omalizumab_ClinPharm_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "68909",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/103976s5149_Omalizumab_Statistical_PREA.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            },
            {
              "id": "9528",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/omalgen062003L.htm",
              "date": "20040330",
              "type": "Letter"
            },
            {
              "id": "18719",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/omalgen062003LB.pdf",
              "date": "20040330",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5165",
          "submission_status": "AP",
          "submission_status_date": "20100730",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5238",
          "submission_status": "AP",
          "submission_status_date": "20210409",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "67021",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103976s5238lbl.pdf",
              "date": "20210412",
              "type": "Label"
            },
            {
              "id": "67031",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/103976Orig1s5238ltr.pdf",
              "date": "20210413",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5102",
          "submission_status": "AP",
          "submission_status_date": "20070702",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "18721",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/103976s5102lbl.pdf",
              "date": "20070702",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5161",
          "submission_status": "AP",
          "submission_status_date": "20140926",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "39772",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103976s5161lbl.pdf",
              "date": "20140930",
              "type": "Label"
            },
            {
              "id": "9529",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/103976Orig1s5161ltr.pdf",
              "date": "20141001",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5242",
          "submission_status": "AP",
          "submission_status_date": "20230817",
          "review_priority": "UNKNOWN",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)",
          "application_docs": [
            {
              "id": "76584",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/103976s5242lbl.pdf",
              "date": "20231116",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5234",
          "submission_status": "AP",
          "submission_status_date": "20190501",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "58524",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/103976Orig1s5234ltr.pdf",
              "date": "20190502",
              "type": "Letter"
            },
            {
              "id": "58529",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103976s5234lbl.pdf",
              "date": "20190502",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA103976",
      "sponsor_name": "GENENTECH",
      "openfda": {
        "application_number": [
          "BLA103976"
        ],
        "brand_name": [
          "XOLAIR",
          "XOLAIR PFS"
        ],
        "generic_name": [
          "OMALIZUMAB"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-040",
          "50242-214",
          "50242-215",
          "50242-227"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "OMALIZUMAB"
        ],
        "rxcui": [
          "1657209",
          "1657212",
          "2058943",
          "2058946",
          "2058949",
          "2058950",
          "2663917",
          "2663918",
          "2663920",
          "2663923",
          "2673760",
          "2673761",
          "2673762",
          "2673763"
        ],
        "spl_id": [
          "e633fdb6-7fbc-4072-93ed-4e30abc6c3a1"
        ],
        "spl_set_id": [
          "7f6a2191-adfb-48b9-9bfa-0d9920479f0d"
        ],
        "package_ndc": [
          "50242-040-62",
          "50242-040-86",
          "50242-214-01",
          "50242-214-86",
          "50242-214-03",
          "50242-214-55",
          "50242-214-99",
          "50242-214-83",
          "50242-215-86",
          "50242-215-01",
          "50242-215-03",
          "50242-215-55",
          "50242-215-99",
          "50242-215-83",
          "50242-227-01",
          "50242-227-55",
          "50242-227-99",
          "50242-227-86"
        ],
        "nui": [
          "N0000175794",
          "N0000175793",
          "N0000175792"
        ],
        "pharm_class_epc": [
          "Anti-IgE [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased IgE Activity [PE]"
        ],
        "pharm_class_moa": [
          "IgE-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "2P471X1Z11"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "XOLAIR",
          "active_ingredients": [
            {
              "name": "OMALIZUMAB",
              "strength": "150MG/VIAL"
            }
          ],
          "dosage_form": "VIAL",
          "route": null,
          "marketing_status": "Prescription"
        },
        {
          "product_number": "004",
          "reference_drug": "No",
          "brand_name": "XOLAIR",
          "active_ingredients": [
            {
              "name": "OMALIZUMAB",
              "strength": "300MG/2ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SYRINGE",
          "route": null,
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "XOLAIR",
          "active_ingredients": [
            {
              "name": "OMALIZUMAB",
              "strength": "75MG/0.5ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SYRINGE",
          "route": null,
          "marketing_status": "Prescription"
        },
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "XOLAIR",
          "active_ingredients": [
            {
              "name": "OMALIZUMAB",
              "strength": "150MG/ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SYRINGE",
          "route": null,
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}